Argitalpenak (47) Mónica Angélica López Rodríguez argitalpenak

2024

  1. Characterization of the plasma proteomic profile of Fabry disease: Potential sex- and clinical phenotype-specific biomarkers

    Translational Research, Vol. 269, pp. 47-63

  2. Monitoring and integrated care coordination of patients with alpha-mannosidosis: A global Delphi consensus study

    Molecular Genetics and Metabolism, Vol. 142, Núm. 4

2023

  1. Oral Sodium Chloride in the Prevention of Contrast-Associated Acute Kidney Injury in Elderly Outpatients: The PNIC-Na Randomized Non-Inferiority Trial

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  2. Screening for late-onset Pompe disease in Internal Medicine departments in Spain

    Orphanet Journal of Rare Diseases, Vol. 18, Núm. 1

2022

  1. Hereditary Hemorrhagic Telangiectasia: Genetics, Pathophysiology, Diagnosis, and Management

    Journal of Clinical Medicine, Vol. 11, Núm. 17

  2. Understanding the ecosystem of patients with lysosomal storage diseases in Spain: a qualitative research with patients and health care professionals

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

2021

  1. Manejo clínico odontológico de un paciente con mucopolisacaridosis tipo III (Síndrome de Sanfilippo)

    Científica dental: Revista científica de formación continuada, Vol. 18, Núm. 5, pp. 25-33

2020

  1. Aortitis in the setting of catastrophic antiphospholipid syndrome in a patient with systemic lupus erythematosus

    Lupus, Vol. 29, Núm. 9, pp. 1126-1129

  2. Consideraciones bucodentales en pacientes con síndrome de Morquio

    Científica dental: Revista científica de formación continuada, Vol. 17, Núm. 2, pp. 27-34

2019

  1. Clinical and pathological characteristics of Castleman disease: an observational study in a Spanish tertiary hospital

    Leukemia and Lymphoma, Vol. 60, Núm. 14, pp. 3442-3448

2018

  1. Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis

    Journal of Inherited Metabolic Disease, Vol. 41, Núm. 6, pp. 1225-1233

  2. Computerized registry of patients with hemorrhagic hereditary telangiectasia (RiHHTa Registry) in Spain: Objectives, methods, and preliminary results

    Revista Clinica Espanola, Vol. 218, Núm. 9, pp. 468-476

  3. Fabry disease in the Spanish population: Observational study with detection of 77 patients

    Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1

  4. Transición desde la asistencia pediátrica a la adulta en pacientes con mucopolisacaridosis

    Revista Clinica Espanola, Vol. 218, Núm. 1, pp. 17-21

  5. Treatment in Fabry disease

    Revista Clinica Espanola

2017

  1. Clinical characteristics of adult patients with inborn errors of metabolism in Spain: A review of 500 cases from university hospitals

    Molecular Genetics and Metabolism Reports, Vol. 10, pp. 92-95

  2. Differences between agalsidase α and agalsidase β in the treatment of Fabry disease

    Medicina Clinica

  3. Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis

    Molecular Genetics and Metabolism, Vol. 121, Núm. 2, pp. 138-149

2016

  1. Proceso de transición de la asistencia pediátrica a la adulta en pacientes con errores congénitos del metabolismo. Documento de consenso

    Medicina Clinica, Vol. 147, Núm. 11, pp. 506.e1-506.e7

2013

  1. Late optic neuropathy in propionic acidemia following surgical intervention

    Journal of Neuro-Ophthalmology